The World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) has initiated the first steps in a long process that could lead to the rescheduling of medical marijuana under international law, and has committed to hold a special session to discuss medical marijuana. Over the next eighteen months, the committee has requested pre-reviews for cannabis plant matter, extracts and tinctures, delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and stereoisomers of THC. This pre-review is a preliminary analysis used to determine if a more in-depth critical review will be undertaken by the ECDD, and will represent the first new scientific guidance on marijuana to the United Nations since 1935, when cannabis was first classified as a Schedule I/IV substance by the Health Committee of the League of Nations. (Full story at medicaljane.com, and the WHO Committee Report)
Posted By: HempToday® January 2, 2017
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.